Related references
Note: Only part of the references are listed.Chronic leg ulcerations associated with livedoid vasculopathy successfully treated with rivaroxaban
D. Miguel et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2020)
Livedoid vasculopathy in Koreans: clinical features and response to rivaroxaban treatment
J. S. Lee et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Successful Treatment of Painful Cutaneous Vasculopathy With Rivaroxaban in a Patient With Systemic Lupus Erythematosus
Nathan H. Leisenring et al.
JOURNAL OF DRUGS IN DERMATOLOGY (2020)
Prevention of recurrent ulceration of livedoid vasculopathy with long-term apixaban monotherapy
Shin-Ichi Osada et al.
JOURNAL OF DERMATOLOGY (2019)
Characteristics, risk factors and treatment reality in livedoid vasculopathy - a multicentre analysis
C. Weishaupt et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
Livedoid Vasculopathy: A French Observational Study Including Therapeutic Options
Emma Gardette et al.
ACTA DERMATO-VENEREOLOGICA (2018)
The management of livedoid vasculopathy focused on direct oral anticoagulants (DOACs): four case reports successfully treated with rivaroxaban
Gabriela Franco Marques et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2018)
Treatment for Livedoid Vasculopathy A Systematic Review
Robert Micieli et al.
JAMA DERMATOLOGY (2018)
Livedoid Vasculopathy: an Updated Review
Robert Micieli et al.
CURRENT DERMATOLOGY REPORTS (2018)
Rapid remission of severe pain from livedoid vasculopathy by apixaban
Y. Yamaguchi et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
Prevention of livedoid vasculopathy recurrence by prolonged administration of rivaroxaban
C. Drerup et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
Treatment application of rivaroxaban in Chinese patients with livedoid vasculopathy
Wenji Chen et al.
JOURNAL OF PAIN RESEARCH (2017)
Case series of recalcitrant livedoid vasculopathy treated with rivaroxaban
J. M. Lee et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2016)
Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial
Carsten Weishaupt et al.
LANCET HAEMATOLOGY (2016)
Successful Treatment of Livedoid Vasculitis with Primary Antiphospholipid Syndrome by Using Aspirin and Low Dose Warfarin Combination Therapy
Byoung Joon So et al.
ANNALS OF DERMATOLOGY (2015)
Response of livedoid vasculopathy to rivaroxaban
D. S. Winchester et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Livedoid Vasculopathy: Clinical Features and Treatment in 24 Chinese Patients
Suying Feng et al.
ACTA DERMATO-VENEREOLOGICA (2014)
Rivaroxaban prevents painful cutaneous infarctions in livedoid vasculopathy
N. Kerk et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Livedoid vasculopathy: An in-depth analysis using a modified Delphi approach
Afsaneh Alavi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
Livedoid vasculopathy in a patient with lupus anticoagulant and MTHFR mutation: treatment with low-molecular-weight heparin
Jihane Abou Rahal et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2012)
Livedoid vasculopathy as a coagulation disorder
Paulo Ricardo Criado et al.
AUTOIMMUNITY REVIEWS (2011)
Livedoid vasculopathy secondary to high levels of lipoprotein(a)
R. Vasconcelos et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Livedoid vasculopathy; favorable clinical response with low dose warfarin
Satoshi Nakamura et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2011)
Case of livedoid vasculopathy with peripheral neuropathy successfully treated with low-dose warfarin
Shin-Ichi Osada et al.
JOURNAL OF DERMATOLOGY (2010)
Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs - a prospective study
T. B. Di Giacomo et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2010)
A case of livedoid vasculopathy associated with factor V Leiden mutation: Successful treatment with oral warfarin
Mukaddes Kavala et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2008)
Ulcerations caused by livedoid vasculopathy associated with a prothrombotic state: Response to warfarin
Mark D. P. Davis et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Methylenetetrahydrofolate reductase polymorphism associated with moderate hyperhomocysteinaemia in a patient with livedo vasculopathy:: treatment with vitamin supplementation and low molecular weight heparin
J. Rampf et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia
CE Browning et al.
ARCHIVES OF DERMATOLOGY (2006)
Refractory livedoid vasculitis responding to PUVA: a report of four cases
C Tuchinda et al.
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE (2005)
Difficult management of livedoid vasculopathy
C Francès et al.
ARCHIVES OF DERMATOLOGY (2004)
Treatment of livedoid vasculopathy with low-molecular-weight heparin - Report of 2 cases
BR Hairston et al.
ARCHIVES OF DERMATOLOGY (2003)
Share Paper
